greeksoup/ stock research
Stock research / United States / NVS / Year to 31 December 2018

Novartis AG (NVS) annual results, year to 31 December 2018: revenue USD 44,833 million, from the 20-F

Novartis AG files a 20-F with the SEC once a year, in US dollars. In the year to 31 December 2018 it reported revenue from the sale of goods of USD 44,833 million, up 5.8% on the year before. Its profit attributable to shareholders was USD 12,611 million, up 63.7%, and diluted earnings per share USD 5.38.

Revenue
USD 44,833 million
+5.8% on the year
FY2016FY2018
Operating margin
18.7%
20.5% a year earlier
FY2016FY2018
Net income
USD 12,611 million
+63.7% on the year
FY2016FY2018
Diluted EPS
USD 5.38
+65.5% on the year
FY2016FY2018

this yearthe year beforeIn US dollars as filed. Hover a bar for its figure.

Income statement (profit and loss)

Year toDec 2017 †Dec 2018 †
Revenue from the sale of goods42,38144,833
Cost of sales13,63314,510
Gross profit29,77131,589
Research and development8,3898,489
Selling, general and administrative12,46513,717
Operating profit8,7028,403
Profit before tax9,10214,095
Income tax1,6031,295
Profit for the year7,70312,614
Profit attributable to shareholders7,70312,611
Filing20-F20-F
USD million, from the 20-F on the SEC's EDGAR, linked in the last row, on the IFRS tags the company filed.
Read moreA line the company does not file under the standard tag is left out rather than estimated.
Year toDec 2017 †Dec 2018 †
Diluted EPS3.255.38
Basic EPS3.285.44
Filing20-F20-F

USD per ordinary share, as filed.

Cash flow

Year toDec 2017 †Dec 2018 †
Cash from operations12,62114,272
Purchase of property, plant and equipment1,3251,254
Free cash flow11,29613,018
Cash from investing-3,119-5,591
Cash from financing-7,733-4,244
Buybacks5,4902,036
Dividends paid6,4956,966
Filing20-F20-F

USD million. Free cash flow is cash from operations less the purchase of property, plant and equipment, arithmetic on the two filed lines.

Balance sheet

Year toDec 2017 †Dec 2018 †
Funded by
Equity attributable to shareholders74,16878,614
Non-controlling interests59.078.0
Borrowings, as filed23,58325,660
Other liabilities35,26941,211
Total equity and liabilities133,079145,563
Owned
Property, plant and equipment16,46415,696
Goodwill31,75035,294
Other intangible assets29,99738,719
Cash and cash equivalents8,86013,271
Inventories6,8676,956
Other assets39,14135,627
Total assets133,079145,563
Filing20-F20-F

USD million, at each fiscal year end.

Ratios on the filed lines

Year toDec 2017 †Dec 2018 †
Return on year-end equity10.4%16.0%
Effective tax rate17.6%9.2%
Filing20-F20-F

Arithmetic on the filed lines of the same year.

20-F for the year to 31 December 2018, filed 26 January 2021: the filing. The figures are in US dollars as filed.